Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE) has reported earnings 17 times since May 12, 2021. The stock moves an average of ±6.84% the day after reporting, closing higher 47.1% of the time. Its largest post-earnings gain was +20% (Mar 18, 2024) and its largest decline was -19.81% (Nov 14, 2022). The next earnings report is predicted for 2026-08-10 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
17
Avg Abs. Movement
±6.84%
Positive %
47.1%
Negative %
52.9%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | ☽ POST | $30.99 | $31.83 | $31.44 | 5,621 | +2.93% | open_in_new |
| Mar 24, 2026 | ☀ PRE | $19.40 | $21.50 | $20.90 | 295,600 | +7.95% | open_in_new |
| Nov 13, 2025 | ☽ POST | $30.24 | $30.49 | $26.49 | 450,600 | -14.04% | open_in_new |
| Aug 11, 2025 | ☽ POST | $21.20 | $21.68 | $20.35 | 133,300 | -5.55% | open_in_new |
| May 09, 2025 | ☀ PRE | $14.65 | $16.00 | $14.73 | 173,000 | -1.8% | open_in_new |
| Mar 24, 2025 | ☽ POST | $14.43 | $14.46 | $13.96 | 240,000 | +1.72% | open_in_new |
| Nov 18, 2024 | ☽ POST | $22.24 | $23.79 | $19.82 | 1,998,100 | -13.07% | open_in_new |
| Aug 09, 2024 | ☀ PRE | $36.20 | $37.74 | $35.59 | 107,500 | -2.63% | open_in_new |
| May 10, 2024 | ☀ PRE | $33.40 | $34.67 | $32.50 | 28,100 | -2.14% | open_in_new |
| Mar 18, 2024 | ☽ POST | $38.50 | $38.50 | $37.55 | 272,800 | +20% | open_in_new |
| Nov 14, 2022 | ☽ POST | $10.56 | $11.20 | $10.60 | 101,690 | -19.81% | open_in_new |
| Aug 09, 2022 | ☽ POST | $21.00 | $21.00 | $19.52 | 15,350 | +0.72% | open_in_new |
| May 09, 2022 | ☽ POST | $24.20 | $25.20 | $22.80 | 10,485 | +0.88% | open_in_new |
| Mar 01, 2022 | ☽ POST | $52.00 | $53.80 | $50.80 | 6,625 | +7.09% | open_in_new |
| Nov 04, 2021 | ☽ POST | $155.80 | $155.80 | $148.80 | 4,595 | +3.36% | open_in_new |
| Aug 05, 2021 | ☽ POST | $132.40 | $152.80 | $150.00 | 9,655 | -6.27% | open_in_new |
| May 12, 2021 | ☀ PRE | $221.80 | $229.90 | $213.60 | 9,000 | -6.32% | open_in_new |
Earnings Count
17
Total earnings in dataset
Avg Abs. Movement
±6.84%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260608 | open_in_new SEC.gov |
| 8-K | 20260604 | open_in_new SEC.gov |
| 4 | 20260508 | open_in_new SEC.gov |
| 4 | 20260507 | open_in_new SEC.gov |
| 144 | 20260506 | open_in_new SEC.gov |
| 3 | 20260420 | open_in_new SEC.gov |
| 8-K | 20260420 | open_in_new SEC.gov |
| ARS | 20260416 | open_in_new SEC.gov |
| DEFA14A | 20260416 | open_in_new SEC.gov |
| DEF 14A | 20260416 | open_in_new SEC.gov |
Frequently asked about NGNE earnings
When does Neurogene Inc. report earnings next? expand_more
Neurogene Inc. (NGNE)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does NGNE stock move after earnings? expand_more
Over 17 reports, NGNE has moved an average of ±6.84% the session after earnings, closing higher 47.1% of the time.
What was NGNE's biggest post-earnings move? expand_more
NGNE's largest post-earnings gain on record was +20% on Mar 18, 2024, and its largest decline was -19.81% on Nov 14, 2022.
Where can I find Neurogene Inc.'s SEC filings? expand_more
All of Neurogene Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right